Abstract
To explore the effect of Multi-Disciplinary Team (MDT) mode in the diagnosis and treatment of Coronavirus Disease 2019 (COVID-19) Pneumonia. A total of 65 patients with suspected COVID-19 pneumonia were included. On February 8, 2020, our hospital officially became a designated hospital for the treatment of COVID-19, and the MDT mode was implemented throughout the diagnosis and treatment for newly admitted patients with suspected COVID-19. The patients were divided into control group and observation group according to whether received MDT mode. Our results showed that the diagnosis time in the observation group was significantly shortened than that in the control group (2.51 days vs. 3.47 days) (p < 0.05). The average daily hospitalization costs in the observation group was significantly decreased in comparison with the control group (¥766.1 vs. ¥1190.4) (p < 0.001). The average daily cost of protective materials in the observation group was significantly reduced in comparison with the control group (¥4226.90 vs. ¥5308.20) (p < 0.001). Compared with the control group, the subjective symptoms of patients in the observation group were significantly improved (p < 0.001). In conclusion, the MDT mode shortens the diagnosis time of, reduces the hospitalization costs, and improves the subjective symptoms of COVID-19.
Highlights
Since December 2019, a number of patients with Coronavirus Disease 2019 (COVID-19) Pneumonia have been found in Wuhan, Hubei Province, China
There was no significant difference in gender, age and occupation between Multi-Disciplinary Team (MDT) group and control group (p > 0.05) (Table 1)
In our daily clinical work, we have found that the consultation process is cumbersome and consumes a lot of human resources
Summary
Since December 2019, a number of patients with Coronavirus Disease 2019 (COVID-19) Pneumonia have been found in Wuhan, Hubei Province, China. With the progress and spread of the epidemic, COVID-19 cases have been found in other areas of China. COVID-19 has been included as an acute respiratory infectious disease into the Class B infectious disease and is managed in accordance with the Class A infectious disease (Huang et al, 2020; China, 2020a). The diagnosis of COVID-19 mainly depends on the positive detection of the viral nucleic acid (Duan & Qin, 2020; China, 2020b). President Xi of China emphasized that “doing a good job in the prevention and control of the epidemic is directly related to the public safety and health, the overall economic and social stability, and reform and opening”. It has become the focus of our hospital’s work that how to improve the efficiency of anti-epidemic and to reduce the anti-epidemic cost on the basis of ensuring zero errors in the diagnosis and treatment process
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
